08:00 , Jan 4, 2016 |  BioCentury  |  Finance

Big band swing

Many investors treated biotech's dismal 3Q15 as a buying opportunity, and the effects were apparent in 4Q15. All of the market cap bands showed positive gains save for the microcaps. Big biotechs led the charge...
08:00 , Dec 14, 2015 |  BC Week In Review  |  Company News

NovaBay ophthalmic news

NovaBay will restructure to reduce operating expenses and focus on the commercialization of Avenova lid and lash cleanser. Mark Sieczkarek will act as interim president and CEO, replacing founder Ron Najafi. In 3Q15, the stable...
08:00 , Dec 9, 2013 |  BC Week In Review  |  Company News

China Pioneer Pharma Holdings, NovaBay deal

The companies again expanded a January 2012 deal granting Pioneer exclusive rights to commercialize wound cleanser NeutroPhase in China and Southeast Asia to include rights to commercialize CelleRx and i-Lid Cleanser in China and 11...